Perspectives
Getting naloxone in the hands of high-risk members
Pharmacists targeted high-risk members at point of sale
February 1, 2019When pharmacists reached out to members picking up an opioid prescription to give them information about naloxone, targeting them at the pharmacy proved impactful.
We knew that members with opioid prescriptions weren’t getting enough information about opioid risks. For this study, Prime used its controlled substance (CS) scoring system to identify members at high risk for opioid overdose and death. When targeted members with high CS scores picked up an opioid prescription, a Walgreens pharmacist provided an Opioid Safety Guide. Members who received an Opioid Safety Guide were four times more likely to get a prescription of naloxone within 6-months, than did members who had not received the Safety Guide.
Related news
Perspectives
May 1, 2024
Prime Therapeutics releases new clinical insights report, “Weight management: A holistic journey”
Report encourages providers to consider health contexts and lifestyle modifications as well as personal preferences and current guidelines when prescribing GLP-1s for weight loss
Perspectives
April 30, 2024
AMCP 2024: Behind the GLP-1 Spotlight Session with Ben Urick
Urick, senior principal health outcomes researcher, shares more about his Spotlight Session at the Academy of Managed Care Pharmacy (AMCP)’s Annual Meeting
Perspectives
April 30, 2024
Quarterly Drug Pipeline
Clinical insights and competitive intelligence on anticipated drugs in development